Predict your next investment

Corporation
HEALTHCARE | Medical Devices & Equipment
bioclinica.com

See what CB Insights has to offer

Founded Year

1990

Stage

Merger | Merged

Revenue

$0000 

About BioClinica

BioClinica provides integrated, technology-enhanced clinical trial management solutions. BioClinica supports pharmaceutical and medical device development with imaging core lab, internet image transport, electronic data capture, interactive voice and web response, clinical trial management, and clinical supply chain forecasting and optimization solutions.On December 10th, 2020, BioClinica merged with eResearchTechnology to form Clario.

BioClinica Headquarter Location

211 Carnegie Center Drive

Princeton, New Jersey, 08540,

United States

877-632-9432

Latest BioClinica News

Clario And XingImaging Expand Partnership To Deliver PET Imaging Clinical Trials In China

Jan 12, 2022

Beijing and Princeton, NJ /PRNewswire/ - Clario, a technology company that delivers the leading endpoint technology solutions for clinical trials, and XingImaging, a radiopharmaceutical production and positron emission tomography (PET) acquisition company, have expanded their partnership to deliver PET imaging clinical trials for testing novel therapeutics in China. Clario, formerly ERT and Bioclinica, and XingImaging joined forces in 2018 to support multi-center clinical trials requiring PET for eligibility and drug efficacy evaluation. PET imaging has supported novel studies for Alzheimer's disease (AD) and other neurodegenerative diseases. A dedicated team of neuroscientists and project managers have led multiple trials in China to date. The new expanded offering leverages the joint resources and neuroscience experts of Clario and XingImaging to expedite the startup of clinical trials and drug discovery in China, including amyloid, tau, and other targets. "Broadening our scope of clinical trials to further support drug development in neuroscience presents a unique opportunity for both patients and clinical researchers," says Joyce Suhy, PhD, SVP Medical Imaging at Clario. "Our continued partnership with XingImaging is advancing therapeutics in APAC." "XingImaging is proud to be working with Clario in providing PET imaging multi-center clinical trials," says Gilles Tamagnan, CEO XingImaging, LLC. "Our partnership enables patients in China to participate in clinical trials testing novel neurodegenerative disease therapeutics." About Clario Clario delivers the leading endpoint technology solutions for clinical trials. Through experience gained from over 19,000 clinical trials delivered in support of 870 regulatory approvals, Clario fuses scientific expertise and global scale into the broadest endpoint technology platform to enable pharmaceutical, biotech and medical device partners to transform lives. Through Trial Anywhere™, Clario has mastered the ability to generate rich evidence across all trial models: decentralized, hybrid and site-based clinical trials. With 30 facilities in nine countries across North America, Europe and Asia Pacific, Clario's global team of science, technology and operational experts has been delivering the richest clinical evidence for nearly 50 years. About XingImaging LLC XingImaging fills the distinctive clinical research role of a radiopharmaceutical production and PET acquisition CRO in the People's Republic of China. Established in January 2018 with that goal, XingImaging is a recognized US based biomarker imaging company leading radiopharmaceutical imaging trials in China. With firmly-rooted study teams on the ground in China and the US, XingImaging works in collaboration with biotech and pharmaceutical companies for the testing and advancement of therapeutics through brain imaging. For more information, please visit Clario.com and XingImaging.com or follow us on LinkedIn and Twitter . Source: Clario

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing BioClinica

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

BioClinica is included in 4 Expert Collections, including Clinical Trials Tech.

C

Clinical Trials Tech

318 items

Companies developing products and services to streamline drug R&D, from drug discovery, pre-clinical testing, and clinical trials.

M

Medical Devices

7,891 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

C

Clinical Trials Tech Market Map

108 items

This CB Insights Tech Market Map highlights 100+ clinical trials tech companies that are addressing 8 distinct technology priorities that pharmaceutical companies and CROs face.

D

Digital Health

12,265 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.